Donald Trump fans were shocked when pics emerged of the president with swollen ankles, later confirmed to be caused by ...

Health experts say chronic venous insufficiency is the most common vascular disease in the country. What is it?

Swollen legs led to President Donald Trump being diagnosed with what's called chronic venous insufficiency. It's a fairly ...

White House doctors diagnosed Donald Trump with chronic venous insufficiency, though the physicians said the US president ...

Over the years, gout has grown in clinical complexity. We see many more cases with iatrogenic factors, multiple comorbidities, advanced age and treatment-refractory hyperuricemia and arthritis ...

“Chronic kidney disease and gout are more connected than many people realize. In fact, 1 in 4 people living with moderate-to-severe CKD also has gout,” he shared.

Gout has often been seen as a consequence of lifestyle choices, but new research is rewriting this narrative. An international team studied DNA from 2.6 million individuals, including 120,295 ...

The expansion of the Krystexxa labeling for coadministration with methotrexate was based on the results of the phase 4 MIRROR trial (ClinicalTrials.gov Identifier: NCT03994731), which evaluated ...

Chronic gout linked to serious conditions including heart and kidney disease Safe and effective treatments needed more than ever as gout numbers expected to increase.

SEL-212, Selecta's lead product, helps control uric acid levels in chronic refractory gout patients. See why I am bearish on SELB stock.

Atom is enrolling patients in the US for a Phase 2b/3 clinical trial for a novel investigational orally administered treatment for chronic gout.

Sobi and Selecta Bio Gout Drug Hits Phase 3 Goals, Paving Way for FDA Submission Sobi said it plans to seek FDA approval of the gout drug, SEL-212, in 2024.